ARK Genomic Revolution ETF (ARKG) News Today $21.43 -2.18 (-9.25%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Market sell-off shakes ETF issuers as Ark Invest gets hit the hardestMarch 18, 2025 | msn.com908 Devices Makes Key Divestiture (Rating Upgrade)March 6, 2025 | seekingalpha.comHC Wainwright & Co. Initiates Coverage of Intellia Therapeutics (NTLA) with Buy RecommendationMarch 5, 2025 | msn.comARK Invest Europe Prepares to Close Rize Digital Payments ETFFebruary 20, 2025 | finance.yahoo.comUnusually active option classes on open February 18thFebruary 18, 2025 | markets.businessinsider.comCathie Wood's ARK buys CRISPR, sells Robinhood in daily tradesFebruary 6, 2025 | msn.comCathie Wood: 'The AI movement has just begun'February 4, 2025 | msn.comCathie Wood's Top Biotech Plays for FebruaryFebruary 2, 2025 | 247wallst.comCathie Wood’s Top Biotech Plays for FebruaryFebruary 2, 2025 | msn.comCathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade StockFebruary 1, 2025 | msn.comCathie Wood's ARK buys Qualcomm and 10X Genomics stockJanuary 30, 2025 | msn.comARKG: Eyeing Favorable Macro 2025 Turns, Encouraging Momentum TrendsJanuary 25, 2025 | seekingalpha.comCathie Wood goes all in on Tempus AI, boosting holdings by over 600K shares in 2025January 23, 2025 | msn.comOptions Alert: Should Investors Jump on This Cathie Wood-Owned Life Sciences Specialist?January 21, 2025 | msn.comCathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-OffJanuary 14, 2025 | finance.yahoo.comUnusually active option classes on open November 25thNovember 25, 2024 | markets.businessinsider.comUnusually active option classes on open November 14thNovember 15, 2024 | markets.businessinsider.comCathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The TableOctober 11, 2024 | msn.comARK Genomic Revolution ETF (BATS:ARKG), Short Interest ReportOctober 4, 2024 | benzinga.comCathie Wood's Ark Invest Dumps Palantir Shares Amidst S&P 500 Inclusion And Extended AI AllianceSeptember 26, 2024 | msn.comCathie Wood’s Stock Shuffle: 1 Stock She’s Loving, 1 She’s LeavingSeptember 7, 2024 | msn.comAlmost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why.August 27, 2024 | fool.comBiotech Stock Soars 60% in 2024: Cathie Wood's Bold InvestmentAugust 23, 2024 | msn.comBMO ARK Genomic Revolution Series I (0P0001PVWY.TO)August 14, 2024 | finance.yahoo.comBMO ARK Genomic Revolution Fund (ARKG.NE)August 9, 2024 | finance.yahoo.comCathie Wood-Led Ark Invest Went Shopping For AMD, Tesla, Amazon, Coinbase, Robinhood, Meta And Palantir Shares Amid Market Crash On MondayAugust 5, 2024 | benzinga.comThe Zacks Analyst Blog Highlights QABA, ITB, XTL, ARKG and SLVPAugust 2, 2024 | finance.yahoo.comCathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance CutAugust 2, 2024 | msn.comCathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy ForecastJuly 20, 2024 | markets.businessinsider.comBMO Transfers 3 BMO Mutual Fund ETF Series, Managed by ARK Investment Management, to Cboe CanadaJune 14, 2024 | businesswire.comBMO to Transfer ETF Series Listing of Three Funds to Cboe CanadaMay 29, 2024 | finance.yahoo.comCathie Wood's Ark Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4MMay 28, 2024 | markets.businessinsider.comCathie Wood Scoops Up Stocks with Solid "Buy" RatingsMay 25, 2024 | msn.comCathie Wood's Ark Invest Buys Shares Of Nvidia-Rival AMD, Continues Its Shopify Share-Buying SpreeMay 20, 2024 | markets.businessinsider.comArk Invest, Led by Cathie Wood, Acquires $3.54M in Shares of Biopharma Company Post Positive Obesity Pipeline UpdateMay 6, 2024 | msn.comCathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline UpdateMay 5, 2024 | msn.comCathie Wood: Macro Environment Will Dictate Launch TimingApril 23, 2024 | finance.yahoo.com3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?April 22, 2024 | fool.comStandard BioTools (LAB) Price Target Decreased by 10.42% to 3.65April 17, 2024 | msn.comARK Genomic Revolution (ARKG) Enters Oversold TerritoryApril 14, 2024 | nasdaq.comCathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play FurtherMarch 26, 2024 | markets.businessinsider.comCathie Wood Is Selling This High-Yield Dividend Stock. Should You?March 25, 2024 | fool.com3 Biotech ETFs Overdue for a BounceMarch 19, 2024 | investorplace.comHere's How Much Cathie Wood, Ark Invest Flagship Fund Missed By Selling Nvidia EarlyFebruary 23, 2024 | markets.businessinsider.comARK Genomic Revolution ETFFebruary 23, 2024 | wsj.comCathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3MFebruary 7, 2024 | markets.businessinsider.comAI Revolution Ignited? Ark Invest Predicts 75% Annual Drop In Training Costs By 2030February 1, 2024 | msn.comCathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF UnitsJanuary 16, 2024 | markets.businessinsider.comARKG February 23rd Options Begin TradingJanuary 6, 2024 | nasdaq.comTuesday's ETF Movers: ARKG, ARKFJanuary 4, 2024 | nasdaq.com Remove Ads Get ARK Genomic Revolution ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter. Email Address ARKG Media Mentions By Week ARKG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARKG News Sentiment▼0.001.01▲Average News Sentiment ARKG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARKG Articles This Week▼00▲ARKG Articles Average Week Remove Ads Get ARK Genomic Revolution ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NLR News Today SPUS News Today ROBO News Today INFL News Today IHAK News Today ARKF News Today BUG News Today ARKQ News Today PNQI News Today TAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (BATS:ARKG) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
